… of a large cohort of patients with antiphospholipid syndrome (APS) from a single center. …
a highly specialized antiphospholipid syndrome center, patients still experienced significant …

… The aim of our study was to report the real-life experience of thrombotic recurrences in APS
patients included in the Piedmont observational cohort study. Secondly, we have attempted: (…

… Indeed in our experience, even considering the limited sample size of our enquired cohort,
patients had to consult multiple physicians to come to a defined diagnosis. With this in mind, …

Background Antiphospholipid syndrome (APS) is an acquired hypercoagulable condition
associated with antiphospholipid antibody (aPL) presence. Data on re-thrombosis following …

… To obtain the best experience, we recommend you use a more up to date browser (or turn
off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we …

… These facts could place this group of patients at a higher thrombotic risk category when
compared with those who experienced aPL negativisation in our cohort. In fact, on one hand, we …

… and conflicting, making extremely relevant the clinical experience of rheumatologists. … the
definition of the hyperferritinemic syndrome, in which four potentially life-threatening conditions …

… In this study we described the real-world experience of 39 CAPS patients treated with
eculizumab, a humanized monoclonal antibody that binds to the C5 complement protein. Despite …

… To obtain the best experience, we recommend you use a more up to date browser (or turn
off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we …

… Antiphospholipid syndrome (APS) is a rare and complex autoimmune disorder … thrombosis
and pregnancy complications in the presence of antiphospholipid antibodies (aPL), including …